Medicine and Dentistry
Pancreas Adenocarcinoma
100%
Pancreas Cancer
91%
Neoplasm
54%
Surgery
35%
Malignant Neoplasm
34%
Overall Survival
30%
Pancreaticoduodenectomy
27%
Disease
27%
Neoadjuvant Therapy
22%
Chemoradiotherapy
21%
Pancreatectomy
20%
Recurrent Disease
19%
Xenograft
16%
Metastatic Carcinoma
16%
Adenocarcinoma
13%
Lymph Node
11%
Cancer Cell
10%
Cancer
10%
Computer Assisted Tomography
8%
Neuroendocrine Tumor
8%
Pancreas Tumor
8%
Pancreatic Ductal Adenocarcinoma
8%
Gemcitabine
7%
Neoadjuvant Chemotherapy
7%
Cancer Staging
7%
Pancreas Islet Cell Tumor
7%
Biological Marker
7%
Postoperative Complication
6%
Hepatectomy
6%
Disease Free Survival
6%
Distal Pancreatectomy
5%
Surgical Oncology
5%
Intraductal Papillary Mucinous Tumor
5%
Bleeding
5%
Adjuvant Therapy
5%
Liver Metastasis
5%
Colorectal Cancer
5%
Radiation Therapy
5%
Odds Ratio
5%
Keyphrases
Pancreatic Ductal Adenocarcinoma
47%
Pancreatic Cancer
42%
Pancreatic Adenocarcinoma
22%
Neoadjuvant Therapy
19%
Pancreaticoduodenectomy
18%
Overall Survival
17%
Tumor
15%
Resectable Pancreatic Cancer
14%
Chemoradiation
11%
Pancreatectomy
10%
Resection
10%
Preoperative Therapy
10%
Cancer Patients
9%
Pancreas
9%
Neoadjuvant Chemoradiotherapy (nCRT)
9%
SMAD4
8%
Borderline Resectable Pancreatic Cancer
6%
Pancreatic Cancer Cells
6%
Chemotherapy
6%
Confidence Interval
6%
Pancreatic Duct Cells
6%
Borderline Resectable
6%
Overexpression
6%
Neoadjuvant Chemotherapy
5%
Patient-derived Xenograft
5%
Disease-free Survival
5%
Adjuvant Therapy
5%
Surgical Resection
5%
Ampullary Adenocarcinoma
5%
Pancreatic Neuroendocrine Tumors (pNETs)
5%
Metastasis
5%
Metastatic Pancreatic Ductal Adenocarcinoma
5%
DPC4
5%